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Mutant UBQLN2P497H in motor neurons
leads to ALS-like phenotypes and defective
autophagy in rats
Tianhong Chen1†, Bo Huang2,3†, Xinglong Shi1, Limo Gao4 and Cao Huang1*
Abstract
Mutations in ubiquilin2 (UBQLN2) have been linked to abnormal protein aggregation in amyotrophic lateral sclerosis
(ALS). The mechanisms underlying UBQLN2-related neurodegenerative diseases remain unclear. Using a tetracycline-
regulated gene expression system, the ALS-linked UBQLN2P497H mutant was selectively expressed in either the spinal
motor neurons or astrocytes in rats. We found that selectively expressing mutant UBQLN2P497H in the spinal motor
neurons caused several core features of ALS, including the progressive degeneration of motor neurons, the
denervation atrophy of skeletal muscles, and the abnormal protein accumulation. Furthermore, mutant UBQLN2P497H
accumulation was associated with an age-dependent decrease in several core autophagy-related proteins. ALS-like
phenotypes were not observed when mutant UBQLN2P497H was overexpressed in the astrocytes, however, even
though the expression of the mutant UBQLN2P497H protein was higher in these rats. Our results suggest that selectively
expressing mutant UBQLN2P497H in motor neurons is sufficient to trigger the development of ALS in rats. Our results
further indicate that the compromised autophagy-lysosomal pathway plays a critical role in the pathogenesis of
UBQLN2-related neurodegenerative diseases.
Keywords: Amyotrophic lateral sclerosis, ALS, UBQLN2, P62, Motor neuron degeneration, Autophagy, Rats, Protein
aggregation
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegen-
erative disease characterized by the degeneration of motor
neurons, progressive muscle wasting, and reduced mobil-
ity [25, 55]. Genetic studies have linked mutations in ubi-
quilin2 (UBQLN2) to both ALS and frontotemporal lobar
degeneration (FTLD) [8, 10, 48]. How UBQLN2 mutations
cause neuronal death remains to be determined.
A prominent feature of Ubqln2-linked diseases is pro-
tein aggregation [8], which is well reproduced in trans-
genic rats and mice overexpressing mutant Ubqln2 [10,
25, 52]. Both TDP-43 pathology and ubiquitination are
common features in a variety of neurological diseases,
including ALS, FTLD, and Alzheimer’s disease (AD) [31,
37]. Ubqln2-positive inclusions exist not just in patients
harboring a Ubqln2 mutation but also in chromosome 9
open reading frame 72 (C9ORF72)-linked cases [5, 8].
Ubqln2 is an X-linked gene that consists of an
ubiquitin-like domain (UBL) at the N-terminus and an
ubiquitin-associated domain (UBA) at the C-terminus
[20]. UBQLN2 shuttles between the nucleus and cyto-
plasm to perform functions related to protein degrad-
ation via proteasomes and autophagy [36, 41]. UBQLN2
inclusion is a well reproduced feature in in vivo models
of ALS [10, 14, 25, 52]. Another ALS-linked gene, p62/
SQSTM1, co-localizes with abnormal UBQLN2 inclu-
sions [8, 10, 14, 52], suggesting a synergistic effect of
UBQLN2 and p62 during neurodegenerative disease
progression. Thus, accumulating evidence in both pa-
tients and rodent models suggests that Ubqln2-positive
inclusions play an important role in proteinopathy in
neurodegenerative disorders.
Although both mutant SOD1 and mutant TDP-43 re-
produce typical ALS features in rodent models, overex-
pression of mutant SOD1 in spinal motor neurons does
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not lead to motor neuron death [29, 39], whereas select-
ive expression of mutant TDP-43 in motor neurons
causes substantial motor neuron death [16] in rats.
These findings suggest different contributions of mutant
SOD1 and mutant TDP43 to ALS. Previous studies have
shown that mutant UBQLN2P497H transgenic rat or
mouse models as well as a UBQLN2P520T knock-in
mouse model harboring the equivalent human P506T
mutation exhibited memory deficits but did not develop
any phenotypes of motor neuron disease [10, 13]. It has
also been shown that selective expression of either
wild-type or ALS–FTLD mutant UBQLN2P497S or
UBQLN2P506T in the motor neurons of mice leads to
both memory deficits and abnormal motor phenotypes
[25]. However, the influence of selectively expressing
ALS-linked mutant UBQLN2 in the spinal motor neu-
rons remains unknown.
As the most abundant glial cells in the central nervous
system (CNS), astrocytes play an important role during
central nervous system (CNS) development [32]. Astro-
cytes also serve as mediators of inflammatory responses
in the CNS [45]. Recent studies suggest, however, that
reactive astrocytes cause detrimental effects in neurons
in several neurological disorders [2, 19, 26, 27, 35]. The
contribution of astrocytes to the pathogenesis of ALS re-
mains controversial.
Here, we show that the selective overexpression of
mutant UBQLN2P497H in the spinal motor neurons led
to age-dependent impairment of motor functions in
ChATtTA/UBQLN2P497H rats, including motor neuron
degeneration, skeletal muscle atrophy, progressive im-
pairment of motor function, TDP-43 pathology, ubiquiti-
nation and glial reactions, and abnormal protein
accumulation. In contrast, selective overexpression of
mutant UBQLN2P497H in astrocytes was not associated
with motor impairment. The accumulation of p62 and
ubiquitin was increased, however, in the spinal cord as-
trocytes of GFAPtTA/UBQLN2P497H rats.
Materials and methods
Generation of transgenic rats
ChATtTA-9 transgenic rats [16] were crossed with
TRE-UBQLNP497H transgenic rats [52] to generate
ChATtTA/UBQLNP497H bigenic rats expressing mutant
UBQLNP497H in motor neurons. All rats were maintained
on a Sprague-Dawley background. Similarly, GFAPtTA-
line-2 transgenic rats [49] were chosen to generate
GFAPtTA/UBQLNP497H bigenic rats that overexpress mu-
tant UBQLNP497H in astrocytes. Multiple sets of primers




TG-3′), and TRE-UBQLNP497H (5′- AGGATCATAATCA
GCCATACCAC-3′ and 5′- CTGCACCTAGTGAAACCA
CGA -3′). To suppress transgene expression in bigenic rats,
breeding rats were fed DOX (50 μg/ml) in their drinking
water during embryonic development. DOX was with-
drawn from the drinking water at birth to induce the ex-
pression of mutant UBQLNP497H transgene [52].
Animal behavior tests
Mobility was tested via open-field and accelerating
rotarod (Med Associates, Inc. VT, USA) tests. The total
distance that a rat traveled in the open field within
10 min was recorded. The latency to fall from the accel-
erating rotarod (0–40 rpm) was recorded over 5 trials
for 2 min per trial.
Cresyl violet staining and cell counting
The transverse sections of the rat spinal cord (L3-L5)
were dissected as previously reported [16], and stained
with cresyl violet for cell counting. Using ImageJ soft-
ware (NIH; Bethesda, MD, USA), both sides of every
10th section (30 μm) were counted for motor neurons
larger than 300 μm2 (i.e., 15–20 sections per rat).
Toluidine blue and silver staining
Rat tissues were fixed in 4% paraformaldehyde. The L3
roots of the spinal cords were dissected for toluidine
blue staining. Transverse sections (5 μm) were stained in
1% toluidine blue. Using ImageJ software, the motor
axons of the entire ventral roots were counted. A modi-
fied Bielschowsky’s silver stain kit (American Master-
Tech; Lodi, CA, USA) was used according to the
manufacturer’s instructions to detect degenerating neu-
rons. Transverse sections (10 μm) were cut by a Leica
CM1950 cryostat for the staining. The degenerating neu-
rons were stained as grey to black and normal neurons
were stained as yellow to gold.
Immunoblotting and fluorescence staining in the spinal
cord
Total proteins of rat tissues were extracted with RIPA buf-
fer and separated via SDS-PAGE for immunoblotting as
described previously [16]. The resolved proteins were
transferred onto nitrocellulose membranes and detected
with the following targeted primary antibodies: rabbit
anti-ATG7 (Cell Signaling Technology; Danvers, MA,
USA), rabbit anti-LAMP2a (Abcam; Cambridge, UK),
mouse anti-GFAP (Millipore; Burlington, MA, USA),
mouse anti-P62 (Novus Biologicals; Littleton, CO, USA),
and mouse anti-GAPDH (Abcam). The spinal cords of
rats were fixed in 4% PFA and then cryopreserved in 30%
sucrose for sections on the cryostat. The tissues were sec-
tioned transversely (20 μm) and stained for the following
antibodies: mouse anti-Ubqln2 (Abnova; Taipei, Taiwan),
goat anti-ChAT (Millipore), rabbit anti-LC3 (Proteintech;
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Rosemont, IL, USA), rabbit anti-GFAP (DAKO; Lexington,
MA, USA), rabbit anti-P62 (Proteintech), chicken anti-
ubiquitin (Sigma; St. Louis, MO, USA) and rabbit
anti-TDP-43 (Proteintech). The tissues were then incu-
bated with the following secondary antibodies: donkey
anti-rabbit IgG Alexa Fluor 488 (ThermoFisher; Waltham,
MA, USA), donkey anti-mouse IgG Alexa Fluor 594
(ThermoFisher), goat anti-chicken IgY Alexa Fluor 488
(ThermoFisher), and donkey anti-goat IgG Alexa Fluor®
488 (Jackson ImmunoResearch; West Grove, PA, USA).
The images were captured by a Nikon digital camera, and
single layer photos were scanned with a Nikon A1R micro-
scope confocal system (Imaging Facility of Kimmel Cancer
Center at Jefferson).
Histology and fluorescence staining for skeletal muscles
Fresh gastrocnemius muscles were snap-frozen in liquid
nitrogen and cut into 10-μm thick sections on a cryostat.
As previously described [16], H&E staining, nonspecific
esterase, and ATPas staining were used to examine struc-
tures in the gastrocnemius muscles. Using the α-napthyl
acetate protocol, nonspecific esterase activity was de-
tected. The red-brown color revealed denervated muscle
fibers, whereas yellow-to-brown color revealed normal fi-
bers. Myosin ATPase staining pH 4.6, which revealed type
1, 2b, and 2c, and pH 10.45, which revealed type 2a and
2b, were used to detect the four types of skeletal muscle fi-
bers. Specific mouse antibodies against myosin from the
Developmental Studies Hybridoma Bank (DSHB; Iowa
City, Iowa) were stained for gastrocnemius muscles along
with DMD (Dystrophin, a plasma membrane marker).
The images were captured by a Nikon digital camera. To
reveal the integrity of the neuromuscular junctions (NMJ),
40-μm thick transverse sections of gastrocnemius muscles
fixed in 4% PFA were stained for α-bungarotoxin conju-
gated with Alexa Fluor 594 (ThermoFisher), mouse mono-
clonal antibodies to neurofilament (ThermoFisher), and
synaptophysin (ThermoFisher). These sections were then
incubated with the secondary antibody donkey anti-mouse
IgG Alexa Fluor 488 (ThermoFisher). The projected im-
ages of the NMJs were captured with a Nikon A1R micro-
scope confocal system.
Statistics
The numbers of motor neurons in the spinal cord or
motor axons in the L3 ventral roots of the spinal cords
were compared among rats using paired t tests. P < 0.05
was considered statistically significant.
Results
Expressing the ALS-linked UBQLN2P497H mutation in
motor neurons of rats
Tetracycline-controlled transcriptional activation is a
commonly used method for inducible gene expression
[54]. A tetracycline-regulated expression system has
proven to be a highly efficient way to regulate transgene
expression in our rat models [15, 16]. As we have previ-
ously reported, expression of the ALS-linked UBQLN2
mutation (P497H substitution) in the forebrain causes
progressive neuron death and learning deficits in rats
[52]. We have also shown that the mouse ChAT pro-
moter region drives the selective expression of the hu-
man TDP-43 transgene in the spinal motor neurons of
rats [16], and the human GFAP promoter also works
well to restrict transgene expression to the astrocytes in
rats [49]. To study the effect of mutant UBQLN2P497H
on motor neurons, we crossed TRE-UBQLN2P497H rats
with the ChATtTA-9 line to produce ChATtTA/
UBQLN2P497H double transgenic rats that selectively ex-
press mutant UBQLN2P497H in the spinal motor neurons
(Fig. 1). This finding is consistent with our previous
study, in which more than 70% of spinal motor neurons
expressed the LacZ transgene or human TDP-43 in the
ChATtTA-9 line [16].
Fifty micrograms (μg) of doxycycline (DOX) was
added to the drinking water to prevent transgene expres-
sion during the prenatal stages (Fig. 1a). To induce the
expression of the transgene UBQLN2P497H, the trans-
genic rats were deprived of DOX after birth. UBQLN2 is
an X-linked gene [8]; therefore, we conducted Western
blots independently on male and female rats, which re-
vealed that only ChATtTA/UBQLN2P497H double trans-
genic rats exhibited human UBQLN2 expression in the
spinal cord at 30 days old. In addition, both female and
male rats had similar expression levels of human
UBQLN2 compared to endogenous UBQLN2, and there
also was no differentiated expression of endogenous
UBQLN2 between male and female rats (Fig 1b, c).
To verify whether endogenous UBQLN2 has similar
expression in both male and female adult rats, different
tissues were examined in non-transgenic rats at 90 days
old via immunoblotting Additional file 1: Figure S1.
There was no statistical difference in the expression
levels of endogenous UBQLN2 between male and female
adult rats at 90 days old Additional file 1: Figure S1. As
described previously in ChATtTA/TDP-43 rats [16], im-
munofluorescence staining revealed that more than 70%
of spinal motor neurons in ChATtTA/UBQLN2P497H
rats expressed human UBQLN2 at 12 months old com-
pared to only 20% at 1 month old (Fig. 1d), but no accu-
mulation of UBQLN2 in ChATtTA rats (Fig. 1e). In
addition, compared to ChATtTA single transgenic rats,
UBQLN2 accumulated in both the nuclei and neurites in
ChATtTA/UBQLN2P497H bigenic rats at 30 days old
(Fig. 1f-i). In contrast, no accumulation in choline ace-
tyltransferase (ChAT, a marker of motor neurons) was
observed (Fig. 1f-g). Thereafter, ChAT was accumulated
in both the nuclei and neurites of most spinal motor
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neurons at 12 months old, and colocalized with
UBQLN2 inclusions (Fig. 1h-i). These results suggest
that selectively expressing mutant UBQLN2P497H in
motor neurons leads to a predominance accumulation of
UBQLN2 inclusions, resulting in abnormal ChAT
accumulation.
Mutant UBQLN2P497H in motor neurons results in ALS-like
phenotypes in rats
DOX was withdrawn at birth to induce mutant
UBQLN2P497H protein expression in rats. Substantial ex-
pression of mutant UBQLN2 in the spinal cord of
ChATtTA/UBQLN2P497H rats was observed via im-
munoblotting (Fig. 1). To investigate the effect of mu-
tant UBQLN2 on motor neurons in rats, the L3-L5
regions of the spinal cord were stained with 0.5% cresyl
violet (Fig. 2a-d). Neurons larger than 300 μm2 were
counted with ImageJ software. There was a decrease in
large neurons compared to ChATtTA single transgenic
rats (Fig. 2e), indicating a loss of motor neurons in
ChATtTA/UBQLN2P497H rats. Consistent with the loss
of motor neurons, there also was a substantial degener-
ation of motor neurons as determined via Bielschowsky’s
silver staining (Fig. 2f-i). The motor axons at the L3 ven-
tral roots were stained with 1% toluidine solution and
quantified, which further revealed a dramatic loss of
large axons larger than 80 μm2 in ChATtTA/
UBQLN2P497H rats at 12 months old (Fig. 2j-l).
Muscle weakness and decreased mobility are two key
features of ALS [4, 28, 55]. As described in a TDP-43 rat
model of ALS [16, 49], both muscular atrophy and loss
of mobility occur as the disease progresses. Body weight
was monitored and behavioral testing was conducted to
investigate the role of mutant UBQLN2 in rats. As
Fig. 1 Restricted expression of the ALS-linked UBQLN2P497H mutation in motor neurons of rats. a A graph showing the tetracycline-regulated expression
system used in this study. The transgene ChATtTA binds to the TRE promoter to induce the expression of mutant human UBQLN2P497H. The presence of Dox
suppresses the expression of the transgene. b-c Immunoblotting shows that human UBQLN2 was expressed in ChATtTA/UBQLN2P497H (P497H) bigenic rats
(TG: T1- T6) but not in control (ChATtTA) rats (non-TG: W1-W6). rUB2: endogenous UBQLN2, hUB2: human UBQLN2. The * indicates unknown bands. The data
are reported as the mean± standard deviation (n =3). d-i Immunofluorescence staining shows that human UBQLN2 is substantially expressed in the spinal
motor neurons of P497H but not ChATtTA rats. In addition, the accumulation of UBQLN2 promoted choline acetyltransferase (ChAT, a marker of motor
neurons) to progressively form inclusions, which colocalized with UBQLN2 inclusions. In (d), a chart shows the quantification of the accumulated UBQLN2 in
motor nuclei (n = 3). In (i), the arrows point to the ChAT inclusions. m: month. Scale bars: 200 μm (d); 50 μm (e-i)
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shown in Fig. 3, rats with mutant UBQLN2P497H exhib-
ited atrophic hind limbs (Fig. 3a) compared with
ChATtTA rats (Fig. 3b), decreased body weight (Fig. 3d),
reduced distance traveled in an open-field test (Fig. 3e),
and reduced latency to fall from an accelerating rotarod
device (Fig. 3f ) compared to ChATtTA single transgenic
rats. Severe muscle wasting (about 50%) in the gastro-
cnemius muscles was observed in mutant UBQLN2P497H
rats at 12 months old (Fig. 3c), whereas no significant al-
terations in either the tibialis or gastrocnemius muscles
were observed at 1 month old (Additional file 1: Figure
S2A-B). In addition, only mild weight loss (about 20%)
was observed at 12 months old. Taken together, these find-
ings indicate that overexpressing mutant UBQLN2P497H in
motor neurons cause the degeneration of both motor neu-
rons and motor axons, progressive deficits in performance
on both open-field and rotarod tests, and reductions in
both body weight and gastrocnemius muscle weight.
We next examined whether mutant UBQLN2 affects
muscle architecture via histology and immunostaining of
the gastrocnemius muscles. H&E staining and histochem-
istry for nonspecific esterase revealed groups of muscle at-
rophy in the gastrocnemius muscles of ChATtTA/
UBQLN2P497H rats. No muscle atrophy was observed in
ChATtTA single transgenic rats (Fig. 4a-h). H&E staining
revealed that a substantial proportion of the nuclei were
located internally in mutant UBQLN2P497H rats compared
to ChATtTA single transgenic rats. Both pH 4.6 and
Fig. 2 Motor neuron degeneration in ChATtTA/UBQLN2P497H rats. a-d Representative images of cresyl violet staining revealed the motor neurons
of the lumbar spinal cord. e A graph showing the relative ratio of the motor neurons of the L3–5 spinal cord counted using ImageJ software.
This graph shows that there was a mild loss of motor neurons in ChATtTA/UBQLN2P497H rats (P497H) at 12 months old. The “m” denotes month
in this graph. The data are reported as the mean ± standard deviation (n = 4). *p < 0.05. f-i Bielschowsky’s silver staining showed degenerating
motor neurons in the ventral horn of spinal cord in ChATtTA/UBQLN2P497H but not in ChATtTA rats. j-k Toluidine staining revealed the L3 ventral
roots of spinal cords. l The motor axons of L3 ventral roots were counted with ImageJ software. The data are shown as the mean ± standard
deviation (n = 4 rats). Scale bars: 50 μm (a-d), 30 μm (f-k)
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pH 10.4 ATPase staining also showed groups of atrophic
muscle fibers, including type 1 and type 2 muscle fibers
(Additional file 1: Figure S3, A and B). Immunofluores-
cence revealed that dystrophic myofibers were accumu-
lated in the gastrocnemius muscles (Additional file 1:
Figure S3, C-F), which further suggests that abnormal pro-
tein inclusion is a prominent feature of UBQLN2-related
diseases [8, 10, 25].
Impairment of neuromuscular junctions is one of the
earliest features to emerge in rodent models of ALS, and
occurs at the presynaptic stage of the disease [33]. Lon-
gitudinal sections of gastrocnemius muscles were labeled
with α-bungarotoxin (to label the motor end-plate) to-
gether with neurofilament and synaptophysin (to label
the neuromuscular synapses). Confocal images showed a
significant amount of denervated neuromuscular junc-
tions (NMJ) in ChATtTA/UBQLN2P497H rats as early as
3 months old but not in ChATtTA single transgenic rats
(Fig. 4i-l), and a substantially increased number of the
denervated NMJs with age (Additional file 1: Figure
S2C), indicating that the neuromuscular synapses are
more vulnerable than the motor neurons in rats that se-
lectively express mutant UBQLN2P497H in the spinal
motor neurons.
Collectively, our results suggest that overexpression of
mutant UBQLN2P497H in the spinal motor neurons leads
to motor neuron degeneration, impaired mobility, de-
nervation atrophy of the skeletal muscles, and accumula-
tion of myofibers in rats.
Age-dependent reduction of autophagy-related proteins
in UBQLN2P497H rats
UBQLN2 plays a role in both the ubiquitin-proteasome
and autophagy-lysosome systems [12, 24, 41]. To detect
whether mutant UBQLN2P497H affected the autophagy
pathway, we examined two autophagy substrates, p62 and
Fig. 3 Overexpression of UBQLN2P497H in motor neurons significantly decreased the mobility of rats. a-b Photos of dystrophic hind limbs in
ChATtTA/UBQLN2P497H (P497H) (a) but not in ChATtTA rats (b) at 12 months old. A red arrow points to the dystrophic hind limb in a P497H rat
compared to a normal hind limb in a ChATtTA rat (yellow arrow). c A graph of the weights of gastrocnemius muscles in the P497H and ChATtTA
male rats at 1 month, 6 months and 12 months old. d The body weights of P497H and ChATtTA male rats. e Analysis of the open-field test
shows the distance traveled during a 10-min trial. f Analysis of the rotarod test shows the latency to fall. The data are reported as the mean ±
standard deviation (n = 4, male rats were used)
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Fig. 4 Denervation atrophy of skeletal muscles in ChATtTA/UBQLN2P497H rats. a-d H&E staining shows groups of atrophic muscle fibers (a, arrows) and
ectopic nuclei (c, arrows) in the gastrocnemius muscles of ChATtTA/UBQLN2P497H (P497H) but not in ChATtTA single transgenic (ChATtTA)
rats at 12 months old. e-h nonspecific esterase staining shows the grouped muscle atrophy (e, g, arrows) in the gastrocnemius muscles
of P497H rats, and which are more severe atrophy in 12-month old rats than 6 months, but not in ChATtTA rats. The red arrows point to
the neuromuscular junctions (NMJ). i-l The projection of confocal images reveals the innervation of NMJs in gastrocnemius muscles. The
arrows (j-l: P497H) show that the motor end-plates are poorly innervated in P497H rats compared to ChATtTA rats (I), and the neurofilaments progressively
form inclusions accompanied with the denervation of NMJ in P497H rats from 3 months to 12 months old. Scale bars: 100 μm (a-b, e-h), 30 μm (c, d),
20 μm (i-l)
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LC3, in the spinal cord of rats. Fluorescence staining re-
vealed that the signals of diffused p62 and LC3 in the
cytoplasm were weaker in the ventral horns in ChATtTA/
UBQLN2P497H rats compared to ChATtTA single trans-
genic rats (Fig. 5a, b). Furthermore, most cytoplasmic p62
was depleted at 12 months old (Fig. 5a). Concomitantly,
p62 predominantly accumulated in the nucleus in
ChATtTA/UBQLN2P497H rats, which also colocalized with
UBQLN2 inclusions (Fig. 5a) or ChAT inclusions (Additional
file 1: Figure S4). We further confirmed these findings in the
spinal cord lysates via immunoblotting (Fig. 5c, d). Interest-
ingly, age-related reductions in LC3-I, LC3-II, and the ratio
Fig. 5 Accumulated UBQLN2 leads to the abnormal accumulation of autophagy-related proteins. a Double staining f p62 and UBQLN2 reveals
that p62 progressively accumulates in the ventral horns of the spinal cord in ChATtTA/UBQLN2P497H (P497H) but not in ChATtTA single transgenic
(ChATtTA) rats. Accumulated p62 colocalizes with UBQLN2 inclusions. The arrows point to the protein inclusions. m: months. b Double staining of
LC3 and UBQLN2 reveals weaker staining of LC3 in P497H rats than in ChATtTA rats. c Western blots of spinal cord lysates at 1 month, 6 months,
and 12 months old probed with the indicated antibodies. d Graphs showing the quantification of human UBQLN2, P62, LAMP2a, LC3-I, LC3-II,
LC3-II/LC3-I, GFAP, TDP-43 and Iba1, all of which are shown in (c). The data are reported as the mean ± standard deviation (n = 3, male rats were
used). e Immunofluorescence staining shows that LAMP2a is accumulated in P497H but not ChATtTA rats at 6-month old. Scale bars: 50 μm
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of LC3-II to LC3-I as well as in p62 were detected. Suppres-
sion of LC3-II and Beclin1 expression reflects impaired au-
tophagy, and LC3-II levels are correlated with the extent of
autophagosome formation [18]. In addition, in patients with
AD, the reduction of functional p62 causes autophagy failure,
which accelerates the development of AD [44, 51]. Our re-
sults are consistent with these findings and indicate that mu-
tant UBQLN2 impairs autophagy in rats.
We also found reduced expression of another autoph-
agy protein, ATG7, and a lysosomal protein, LAMP2a,
which acts as a receptor in the lysosomal membrane for
substrate proteins of chaperone-mediated autophagy [7].
LAMP2a was accumulated in the spinal cord sections of
ChATtTA/UBQLN2P497H rats and colocalized with
UBQLN2 inclusions (Fig. 5e). Taken together, our find-
ings suggest that mutant UBQLN2P497H compromises
the autophagy-lysosomal pathway in rats.
TDP-43 pathology and ubiquitination in ChATtTA/
UBQLN2P497H rats
Previous reports have shown that UBQLN2 inclusions
co-exist with TDP-43 inclusions in patients with ALS
[8, 41]. UBQLN2 also binds to the C-terminal region
of TDP-43 [6]. Furthermore, pathologic TDP-43 is
also hyper-phosphorylated [37]. We stained the cor-
onal sections of spinal cord with phosphorylated
TDP-43 antibody (S403-TDP-43), and found that
phosphorylated TDP-43 was accumulated in
ChATtTA/UBQLN2P497H rats but did not colocalize
with UBQLN2-positive inclusions (Fig. 6a). We did
not detect any obvious reduction of nuclear TDP-43
by fluorescence staining (data not shown), but the
total TDP-43 was decreased with age in ChATtTA/
UBQLN2P497H rats by immunoblot (Fig. 5c).
UBQLN2 binds to ubiquitin via its C-terminal ubi-
quitin associated domain [9, 21]. We therefore exam-
ined whether UBQLN2 inclusions promoted the
accumulation of ubiquitin in ChATtTA/UBQLN2P497H
rats. Double immunofluorescence staining revealed
that only minimal ubiquitin accumulation in the
spinal cord of ChATtTA/UBQLN2P497H rats occurred.
In contrast, no accumulation was observed in
ChATtTA rats (Fig. 6b). Accumulated ubiquitin colo-
calized with UBQLN2 inclusions, as shown by con-
focal single-scan images (Fig. 6b). Substantially
increased GFAP expression was observed in the spinal
cord lysates of ChATtTA/UBQLN2P497H rats com-
pared to ChATtTA rats (Fig. 5c, d), but there were
no obvious alterations in microglia via immunoblot-
ting with IBa1. Thus, our findings suggest that both
the phosphorylation of TDP-43 and the ubiquitin in-
clusions that are observed in ALS patients could be
replicated in our rat model.
Mutant UBQLN2P497H in astrocytes does not cause motor
deficits in rats
To test whether mutant UBQLN2 expressed in astro-
cytes induces motor neuron death, we crossed TRE-
UBQLN2P497H rats with the GFAPtTA#2 line (Fig. 7a).
As previously reported [49], the GFAPtTA#2 line is
driven by a 21-kb human GFAP promoter, which in-
duces restricted transgene expression in the astrocytes
of spinal cord and brain. As in the ChATtTA/
UBQLN2P497H experiments, GFAPtTA/UBQLN2P497H
rats were deprived of DOX at birth. One month after
DOX deprivation, immunoblotting revealed a substantial
expression of human UBQLN2 in the spinal cord, which
was similar in level to the expression of endogenous
UBQLN2 (Fig. 7b, c). Compared to ChATtTA/
UBQLN2P497H rats, in which expression of human
UBQLN2 accounted for about 20% of endogenous
UBQLN2 expression, GFAPtTA/UBQLN2P497H rats
expressed higher amounts of transgene in the spinal
cord. Immunofluorescence staining revealed accumu-
lated UBQLN2 in the spinal cord astrocytes of
GFAPtTA/UBQLN2P497H but not in GFAPtTA rats at
6 months old (Fig. 7d-e).
To examine their mobility, GFAPtTA/UBQLN2P497H
rats were subjected to monthly open-field and rotarod
tests. No significant behavioral differences between
GFAPtTA/UBQLN2P497H rats and GFAPtTA rats were ob-
served. In contrast to the rats that expressed mutant
UBQLN2P497H in motor neurons, no reduction in mobil-
ity, no motor neuron loss, no muscular atrophy, and no
obvious denervation of neuromuscular junctions were ob-
served in GFAPtTA/UBQLN2P497H rats at 6 months old
(Fig. 8). In addition to UBQLN2, however, both p62 and
ubiquitin also were accumulated in the spinal cord astro-
cytes of GFAPtTA/UBQLN2P497H but not GFAPtTA rats
(Additional file 1: Figure S5). And we did not detect any
pathological alterations in phosphorylated TDP-43, LC3,
Lamp2a, and ATG7 (data not shown). These findings sug-
gest that mutant UBQLN2 expression in astrocytes does
not lead to motor phenotypes in 6-month old rats.
Discussion
Mutations in UBQLN2 have been linked to ALS-FLTD,
and the abnormal accumulation of UBQLN2 inclusions is
a remarkable feature of pathological alterations linked to
the UBQLN2 mutation [8, 46]. Several groups have reca-
pitulated this specific pathological change in rodent
models [10, 13, 25, 52]. No studies to date, however, have
shown the effect of expressing mutant UBQLN2 either in
the motor neurons or in the astrocytes to test whether
mutant UBQLN2 expression leads to motor neuron de-
generation in a cell-autonomous manner. To test this hy-
pothesis, therefore, we created novel transgenic models
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expressing mutant UBQLN2P497H in the spinal motor
neurons or astrocytes in rats.
One recent report showed that transgenic mice ex-
pressing either the UBQLN2 P497S or P506T mutation
developed both cognitive deficits and motor phenotypes,
including progressive reduction of mobility, progressive
loss of motor neurons in the spinal cord, and denerv-
ation of skeletal muscles as well as abnormal accumula-
tion of UBQLN2 inclusions [25]. Similar motor
phenotypes were observed in our novel ChATtTA/
TRE-UBQLN2P497H transgenic rats. In particular, de-
nervation atrophy of the gastrocnemius muscles was ob-
served as early as 3 months old, but loss of motor
neurons was not detected at that age. The motor pheno-
types, however, appeared for even low levels of mutant
UBQLN2 (about 20% of the endogenous levels). In con-
trast, disease did not develop in SOD1G93A mice until
the levels of mutant SOD1 were three times that of en-
dogenous SOD1 protein [11]. Moreover, both Gorrie et
al. [10] and Hjerpe et al. [13] reported progressive accu-
mulation of UBQLN2 inclusions and progressive cogni-
tive deficits in mice expressing either the UBQLN2
P497H or P506T mutation. All these findings indicate
that mutant UBQLN2 leads to neuron degeneration in
rodent models. Furthermore, the abnormal accumulation
of UBQLN2 inclusions is a remarkable pathological fea-
ture of UBQLN2-related diseases.
Similar findings have been reported in transgenic rats
expressing mutant TDP43 (M337 V substitution) in the
spinal motor neurons, which causes rapid degeneration
of motor neurons and paralysis [16]. In contrast, trans-
genic mice expressing mutant SOD1 in the motor neu-
rons do not develop motor phenotypes [29, 50]. The
causes of these differences remain unknown. One pos-
sible reason for these differences is that different disease
mechanisms may underlie UBQLN2, TDP-43, and SOD1
genes. For example, UBQLN2 involves protein degrad-
ation via both autophagy and the ubiquitin-proteasome
Fig. 6 Accumulation of phosphorylated TDP-43 and ubiquitin in ChATtTA/UBQLN2P497H rats. a Confocal images of phosphorlated TDP-43 (S403-TDP-43)
and UBQLN2 staining in the spinal motor neurons of ChATtTA/UBQLN2P497H rats shows that S403-TDP-43 positive inclusions do not colocalize with
accumulated UBQLN2. b Confocal images of ubiquitin and UBQLN2 show that ubiquitin and UBQLN2 inclusions colocalize in P497H but not ChATtTA rats.
The arrows point to the colocalized inclusions. Scale bars: 20 μm
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pathway [9, 13, 36, 41, 53]. The overexpression of
UBQLN2P497H in the spinal motor neurons caused the
autophagy substrate p62 to progressively accumulate as
well as colocalize with both UBQLN2 and ChAT inclu-
sions in the ventral horn of spinal cord in ChATtTA/
UBQLN2P497H rats, which is similar to the results from
transgenic rats expressing UBQLN2 in forebrain neurons
[14, 52]. At 12 months old, p62 accumulated predomin-
antly in the nucleus and cytoplasmic p62 was mostly de-
pleted. Under physiological conditions, however, p62 is
commonly considered a cytoplasmic protein. p62 con-
tains two nuclear localization signals (NLS) and a nu-
clear export signal, however, and it has been confirmed
that p62 also shuttles between the nucleus and cyto-
plasm, a process that is regulated by the phosphorylation
of NLS [38]. The mislocalization of p62, as observed in
our study, may be the underlying cause of the abnormal
functions observed in our ChATtTA/UBQLN2P497H rats.
Total p62 was increased in ChATtTA/UBQLN2P497H
rats at 1 month old, which is similar to the findings in
rats expressing mutant UBQLN2 in the forebrain [52].
As an autophagy substrate, p62 is essential to neurons
[22], and mutations in p62 have been linked to ALS and
FTLD [42]. In mouse models, loss of p62 leads to neuro-
degeneration [40]. Our finding that accumulated p62 co-
localizes with UBQLN2 inclusions is similar to our
previous reports in other rat models [14, 52]. These find-
ings imply that the two disease genes may share similar
mechanisms underlying neurodegeneration. Specifically,
mutant UBQLN2P497H may compromise the functions of
autophagy, leading to abnormal protein accumulations
of UBQLN2, p62, and others.
Although p62 has been used as one indicator of au-
tophagy [3, 30, 43], autophagic flux should be measured
by an LC3 turnover assay in addition to p62. LC3-II is
one isoform of LC3, and is widely used to measure the
autophagic process [22, 47]. The suppression of LC3-II
expression reflects impaired autophagy, and the amount
of LC3-II is correlated with the extent of autophagosome
formation [18]. ATG7 is another autophagy component
that is essential for autophagosome formation. The loss
of ATG7 leads to the reduction of autophagy in mice
[23]. In our ChATtTA/UBQLN2P497H rats, both LC3
and ATG7 were accumulated at 1 month old but
Fig. 7 Expression of mutant UBQLN2P497H in the astrocytes of rats. a A graph of the GFAPtTA construct. The trasgene is regulated by DOX. b-cWestern
blots show the relative expression level of human UBQLN2 in bigenic GFAPtTA/UBQLN2P497H (P497H: TG) but not in control rats (GFAPtTA: CT) at 1 month
old. rUB2: endogenous UBQLN2, hUB2: human UBQLN2, and the * indicates unknown bands. The data are reported as the mean ± standard deviation
(n = 4, female rats were used). d-e The projection of confocal images shows the expression of human UBQLN2P497H in the astrocytes of spinal cords in
P497H but not in GFAPtTA rats. At 6 months old, a substantial proportion of UBQLN2 inclusions are mislocalized into the nuclei of astrocytes in P497H rats
(e). Scale bars: 20 μm
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Fig. 8 (See legend on next page.)
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decreased substantially after 6-month old. Similarly, the
lysosomal membrane protein LAMP2a also was accumu-
lated and colocalized with UBQLN2 inclusions in
12-month old ChATtTA/UBQLN2P497H rats. Consistent
with these findings, the selective loss of LAMP2A pro-
tein directly correlated with increased levels of
α-synuclein in early Parkinson’s disease [34]. All these
results suggest that mutant UBQLN2P497H compromises
autophagy-lysosomal pathways in an age-dependent
manner. Moreover, the decrease of several core ATG
proteins suggests that mutant UBQLN2P497H is more
likely to suppress autophagy at upstream stages.
The hyperphosphorylated form of TDP-43 has been
identified as a core component of cytosolic inclusions in
sporadic ALS [1, 37]. In ChATtTA/UBQLN2P497H rats,
relatively little phosphorylated TDP-43 was detected in
the spinal cord and did not colocalize with UBQLN2 in-
clusions. In contrast, accumulated ubiquitin was coloca-
lized with UBQLN2 inclusions. Ubiquitin accumulation
is one of the key pathological alterations in neurodegen-
erative diseases, and ubiquitin accumulation may correl-
ate with neurodegeneration in our rats. In contrast, the
expression of the astrocyte marker GFAP was elevated
in our rats, but no significant changes in IBa1, a marker
of microglia, were observed. These findings are different
from those of other rodent models, in which increased
expression in both astrocytes and microglia have been
observed [16, 17, 25, 52]. This difference may be due to
the slow progression of the disease and a mild loss of
motor neurons in ChATtTA/UBQLN2P497H rats com-
pared to other rat models, indicating that astrocytes are
more sensitive to stress conditions than microglia in our
mutant UBQLN2P497H rats.
We did not observe any motor deficits at 6-month old
GFAPtTA/UBQLN2P497H rats, which is not consistent
with the motor phenotypes observed in mutant TDP-43
or mutant SOD1 rodent models [26, 35, 49]. Mutant
UBQLN2 protein expression was higher in the spinal
cord of GFAPtTA/UBQLN2P497H rats compared to
ChATtTA/UBQLN2P497H rats. These findings suggest
that phenotypes caused by mutant UBQLN2P497H are
not dependent solely on the expression level of mutant
proteins in motor neurons and astrocytes in rats. It
would be important to investigate whether any disease
phenotypes can be induced in older rats (up to
18 months old) expressing mutant UBQLN2P497H in as-
trocytes. In addition, future studies are needed to exam-
ine whether mutant UBQLN2 will initiate motor neuron
degeneration in a non-cell autonomous manner when
overexpressing mutant UBQLN2 in other non-neuronal
cells, such as microglia or oligodendrocytes.
Conclusions
Our results showed that mutant UBQLN2P497H select-
ively expressed in motor neurons other than astrocytes
leads to several key features of motor neuron disease in
rats, including abnormal accumulation of UBQLN2, p62,
and ChAT; mobility impairment; motor neuron degener-
ation; and reductions in several core autophagy-related
proteins. This study indicates that expressing mutant
UBQLN2 in motor neurons leads to progressive motor
deficits and impairment of the autophagy-lysosomal
pathway, but that overexpression of mutant UBQLN2 in
astrocytes alone is not sufficient to develop motor phe-
notypes or defective autophagy.
Additional file
Additional file 1: Figure S1. Similar expression of UBQLN2 in male and
female non-transgenic rats. Western blotting showed the endogenous
UBQLN2 (rUB2) had no differential expression between male and female
non-transgenic rats at the age of 90 days. The upper graph showed the
relative ratios of endogenous UBQLN2 between female and male among
different tissues. (M: male, F: female. “*” denotes non-specific band). Data are
shown as mean ± s.d. (n = 3). Figure S2. Muscle structures in rats. (A-B),
H&E staining showed no alteration was observed in both tibialis anterior
and gastrocnemius muscles of ChATtTA/UBQLN2P497H rats (P497H) com-
pared with ChATtTA single transgenic rats (ChATtTA) at 1 month old. Panel
A: 4x objective, and Panel B: 10x objective. Scale bars: A (250 μm), B
(100 μm). (C), Quantification of the impaired neuromuscular junctions in
P497H rats at indicated ages, which are the same rats shown in Fig. 4i-l. (>
20 NMJs were counted randomly for each rats). Figure S3. Accumulation of
myofibers in ChATtTA/UBQLN2P497H rats. (A-B), Both pH 4.6 and pH 10.4
ATPase staining revealed groups of atrophic muscle fibers in gastrocnemius
muscles of ChATtTA/UBQLN2P497H rats (P497H) at 12 months old, not in
the age-matched ChATtTA single transgenic rats (ChATtTA). (C-F), Immuno-
fluorescent staining of myofibers (MYH-S and MYH-1) and DMD (a plasma
membrane protein) showed the atrophic myofibers accumulated in gastro-
cnemius muscles of P497H rats, not in ChATtTA rats. Arrows point to groups
of myofiber atrophy. Scale bars: 100 μm. Figure S4. The colocalization of
the accumulated ChAT and p62 in rats. (A-C), Double staining of p62 and
ChAT revealed the accumulation of p62 in ChATtTA/UBQLN2P497H rats
(P497H, arrows point to the accumulations), not in ChATtTA single trans-
genic rats (ChATtTA). At 12 months old, a substantial proportion of ChAT
mislocalilzed into nuclei and also colocalized with the p62 inclusions (C).
Scale bars: 100 μm. Figure S5. Accumulations of P62 and ubiquitin in
(See figure on previous page.)
Fig. 8 No motor phenotypes in GFAPtTA/UBQLN2P497H rats. a-b Results of beavioral tests in GFAPtTA/UBQLN2P497H bigenic (P497H) and GFAPtTA
single transgenic rats. c The weights of tibialis anterior and gastrocnemius muscles at 6 months old in P497H and GFAPtTA female rats. The data are
reported as the mean ± standard deviation (n = 4). d-g H&E staining shows the structures of gastrocnemius muscle in both P497H and GFAPtTA rats;
h-l Cresyl violet staining shows the motor neurons in the ventral horn of the spinal cord. The quantification of motor neurons in the L3–5 spinal cord
shows that there is no statistical difference between P497H and GFAPtTA rats (n = 4). m-n Confocal images show the structures of neuromuscular
junctions (NMJ) in gastrocnemius muscles. The sections were stained with the presynaptic neuronal marker neurofilament (NF) and synaptophysin
together with α-bungarotoxin to show the post-synaptic structures. Scale bars: 100 μm (d, e, h, i), 50 μm (j, k), 30 μm (f, g), 20 μm (m, n)
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GFAPtTA/UBQLN2P497H rats. (A), Double staining of P62 and GFAP revealed
the accumulations of P62 were colocalized with astrocytes in GFAPtTA/
UBQLN2P497H rats (P497H, arrows point to the colocalizations of inclusions),
not in GFAPtTA single transgenic rats (GFAPtTA). (B), The projected confocal
images of ubiquitin and GFAP showed the colocalization of the accumu-
lated ubiquitin and astrocytes in P497H rats (arrows point to the colocaliza-
tions), not in GFAPtTA rats. Scale bars: 30 μm (A), 20 μm (B). (PDF 1240 kb)
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